USE OF GLP-1 RECEPTOR AGONISTS AND/OR SGLT-2 INHIBITORS AMONG PATIENTS WITH PERIPHERAL ARTERY DISEASE BEFORE AND AFTER REVASCULARIZATION IN A SINGLE-CENTER COHORT

Therapeutic Area: Peripheral Artery Disease Background: Diabetes mellitus (DM) is a major risk factor for peripheral artery disease (PAD). Patients with both PAD and DM have an increased risk of major adverse atherosclerotic events. GLP-1 RA and SGLT-2i are recommended to improve major adverse cardi...

Full description

Saved in:
Bibliographic Details
Main Author: Franck H. Azobou Tonleu, MD (Author)
Format: Book
Published: Elsevier, 2024-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available